BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31028751)

  • 21. GSK-3 inhibition reverts mesenchymal transition in primary human corneal endothelial cells.
    Maurizi E; Merra A; Macaluso C; Schiroli D; Pellegrini G
    Eur J Cell Biol; 2023 Jun; 102(2):151302. PubMed ID: 36905755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial mesenchymal transition: a therapeutic target in retrocorneal membrane.
    Miyamoto T; Sumioka T; Saika S
    Cornea; 2010 Nov; 29 Suppl 1():S52-6. PubMed ID: 20935543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor 2 induces proliferation and fibrosis via SNAI1-mediated activation of CDK2 and ZEB1 in corneal endothelium.
    Lee JG; Jung E; Heur M
    J Biol Chem; 2018 Mar; 293(10):3758-3769. PubMed ID: 29363574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing.
    Okumura N; Koizumi N; Kay EP; Ueno M; Sakamoto Y; Nakamura S; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2493-502. PubMed ID: 23462749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a p38 Mitogen-Activated Protein Kinase Inhibitor on Corneal Endothelial Cell Proliferation.
    Nakahara M; Okumura N; Nakano S; Koizumi N
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4218-4227. PubMed ID: 30128493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotinamide promotes the differentiation of functional corneal endothelial cells from human embryonic stem cells.
    Zou D; Wang T; Li W; Wang X; Ma B; Hu X; Zhou Q; Li Z; Shi W; Duan H
    Exp Eye Res; 2024 May; 242():109883. PubMed ID: 38561106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corneal Endothelial Cell Migration and Proliferation Enhanced by Rho Kinase (ROCK) Inhibitors in In Vitro and In Vivo Models.
    Meekins LC; Rosado-Adames N; Maddala R; Zhao JJ; Rao PV; Afshari NA
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6731-6738. PubMed ID: 27951595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo.
    Nakano Y; Oyamada M; Dai P; Nakagami T; Kinoshita S; Takamatsu T
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):93-104. PubMed ID: 18172080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Descemet's Membrane Supports Corneal Endothelial Cell Regeneration in Rabbits.
    Chen J; Li Z; Zhang L; Ou S; Wang Y; He X; Zou D; Jia C; Hu Q; Yang S; Li X; Li J; Wang J; Sun H; Chen Y; Zhu YT; Tseng SCG; Liu Z; Li W
    Sci Rep; 2017 Aug; 7(1):6983. PubMed ID: 28765543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitronectin: a migration and wound healing factor for human corneal epithelial cells.
    Chow S; Di Girolamo N
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6590-600. PubMed ID: 25237160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of Corneal Endothelial Cells from Periphery after Injury.
    Choi SO; Jeon HS; Hyon JY; Oh YJ; Wee WR; Chung TY; Shin YJ; Kim JW
    PLoS One; 2015; 10(9):e0138076. PubMed ID: 26378928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corneal endothelial wound closure in vitro. Effects of EGF and/or indomethacin.
    Joyce NC; Matkin ED; Neufeld AH
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1548-59. PubMed ID: 2787301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction.
    Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Hamuro J; Kinoshita S
    Cornea; 2011 Oct; 30 Suppl 1():S54-9. PubMed ID: 21912232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with solubilized Silk-Derived Protein (SDP) enhances rabbit corneal epithelial wound healing.
    Abdel-Naby W; Cole B; Liu A; Liu J; Wan P; Schreiner R; Infanger DW; Paulson NB; Lawrence BD; Rosenblatt MI
    PLoS One; 2017; 12(11):e0188154. PubMed ID: 29155856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro pharmacologic separation of corneal endothelial migration and spreading responses.
    Joyce NC; Meklir B; Neufeld AH
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1816-26. PubMed ID: 2211027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of TGF-β signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine.
    Okumura N; Kay EP; Nakahara M; Hamuro J; Kinoshita S; Koizumi N
    PLoS One; 2013; 8(2):e58000. PubMed ID: 23451286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Hydrogen Attenuated N-methyl-N-Nitrosourea Induced Corneal Endothelial Injury by Upregulating Anti-Apoptotic Pathway.
    Li R; Qu Y; Li X; Tao Y; Yang Q; Wang J; Diao Y; Li Q; Fang Y; Huang Y; Wang L
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):2. PubMed ID: 34196654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZEB1 Mediates Fibrosis in Corneal Endothelial Mesenchymal Transition Through SP1 and SP3.
    Lee J; Jung E; Gestoso K; Heur M
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):41. PubMed ID: 32721022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smad7 suppresses the inhibitory effect of TGF-beta2 on corneal endothelial cell proliferation and accelerates corneal endothelial wound closure in vitro.
    Funaki T; Nakao A; Ebihara N; Setoguchi Y; Fukuchi Y; Okumura K; Ra C; Ogawa H; Kanai A
    Cornea; 2003 Mar; 22(2):153-9. PubMed ID: 12605052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
    Kim JW; Jeong H; Yang MS; Lim CW; Kim B
    Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.